Federal contract award
HT940626FE026
CLINICAL CHEMISTRY COST PER REPORTABLE RESULT
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | DEFENSE HEALTH AGENCY |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets |
| Parent award / vehicle | W9114F26DA005 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $42.4K |
| Current contract value | $42.4K |
| Potential contract value / ceiling | $42.4K |
| Start date | Mar 1, 2026 |
| Current end date | Sep 30, 2026 |
| Potential end date | Sep 30, 2026 |
| Latest award activity | Feb 26, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Feb 26, 2026 | 0 | $42.4K | CLINICAL CHEMISTRY COST PER REPORTABLE RESULT |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.